Annual D&A
$5.36 M
+$508.90 K+10.49%
March 31, 2023
Summary
- As of February 10, 2025, YS annual depreciation & amortization is $5.36 million, with the most recent change of +$508.90 thousand (+10.49%) on March 31, 2023.
- During the last 3 years, YS annual D&A has risen by +$1.24 million (+30.10%).
Performance
YS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2.75 M
NaN%
September 30, 2023
Summary
- As of February 10, 2025, YS quarterly depreciation & amortization is $2.75 million
- Over the past year, YS quarterly D&A has increased by +$239.60 thousand (+9.53%).
Performance
YS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
$2.75 M
NaN%
September 30, 2023
Summary
- As of February 10, 2025, YS TTM depreciation & amortization is $2.75 million
- Over the past year, YS TTM D&A has increased by +$239.60 thousand (+9.53%).
Performance
YS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
YS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.5% | +9.5% | +9.5% |
| 3 y3 years | +30.1% | - | - |
| 5 y5 years | +30.1% | - | - |
YS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -23.1% | at high | -8.7% | at high | -8.7% |
| 5 y | 5-year | at high | -23.1% | at high | -8.7% | at high | -8.7% |
| alltime | all time | at high | -23.1% | at high | -8.7% | at high | -8.7% |
YS Biopharma Co Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $2.75 M(+9.5%) | $2.75 M(+9.5%) |
| Mar 2023 | $5.36 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $2.52 M | $2.52 M |
| Mar 2022 | $4.85 M(+17.7%) | - | - |
| Mar 2021 | $4.12 M | - | - |
FAQ
- What is YS Biopharma Co annual depreciation & amortization?
- What is the all time high annual D&A for YS Biopharma Co?
- What is YS Biopharma Co annual D&A year-on-year change?
- What is YS Biopharma Co quarterly depreciation & amortization?
- What is the all time high quarterly D&A for YS Biopharma Co?
- What is YS Biopharma Co quarterly D&A year-on-year change?
- What is YS Biopharma Co TTM depreciation & amortization?
- What is the all time high TTM D&A for YS Biopharma Co?
- What is YS Biopharma Co TTM D&A year-on-year change?
What is YS Biopharma Co annual depreciation & amortization?
The current annual D&A of YS is $5.36 M
What is the all time high annual D&A for YS Biopharma Co?
YS Biopharma Co all-time high annual depreciation & amortization is $5.36 M
What is YS Biopharma Co annual D&A year-on-year change?
Over the past year, YS annual depreciation & amortization has changed by +$508.90 K (+10.49%)
What is YS Biopharma Co quarterly depreciation & amortization?
The current quarterly D&A of YS is $2.75 M
What is the all time high quarterly D&A for YS Biopharma Co?
YS Biopharma Co all-time high quarterly depreciation & amortization is $2.75 M
What is YS Biopharma Co quarterly D&A year-on-year change?
Over the past year, YS quarterly depreciation & amortization has changed by +$239.60 K (+9.53%)
What is YS Biopharma Co TTM depreciation & amortization?
The current TTM D&A of YS is $2.75 M
What is the all time high TTM D&A for YS Biopharma Co?
YS Biopharma Co all-time high TTM depreciation & amortization is $2.75 M
What is YS Biopharma Co TTM D&A year-on-year change?
Over the past year, YS TTM depreciation & amortization has changed by +$239.60 K (+9.53%)